• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一氧化氮供体在心血管和肺部疾病治疗中的应用

Nitric oxide donors in the treatment of cardiovascular and pulmonary diseases.

作者信息

Loskove J A, Frishman W H

机构信息

Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.

出版信息

Am Heart J. 1995 Mar;129(3):604-13. doi: 10.1016/0002-8703(95)90291-0.

DOI:10.1016/0002-8703(95)90291-0
PMID:7872193
Abstract

NO has been shown to be a biologic substance important to normal physiologic functioning. It appears to be an endogenous vasodilator and is involved in hemostasis and inflammation. Endothelial cell dysfunction often leads to diminished NO production; this reduction in NO concentrations may be an etiologic factor in systemic hypertension, myocardial and splanchnic ischemia, atherosclerosis, CHF, and pulmonary vascular disease. A new class of drugs, NO donors, have potential utility in the treatment of coronary and pulmonary arterial diseases. Their major advantage over nitrates and nitroprusside is a lack of pharmacologic tolerance. Clinical trials with drugs of this class are now in progress.

摘要

一氧化氮已被证明是一种对正常生理功能很重要的生物物质。它似乎是一种内源性血管舒张剂,参与止血和炎症过程。内皮细胞功能障碍常导致一氧化氮生成减少;一氧化氮浓度的这种降低可能是系统性高血压、心肌和内脏缺血、动脉粥样硬化、心力衰竭和肺血管疾病的一个病因。一类新型药物,即一氧化氮供体,在治疗冠状动脉和肺动脉疾病方面具有潜在用途。它们相对于硝酸盐和硝普钠的主要优势是缺乏药理学耐受性。这类药物的临床试验正在进行中。

相似文献

1
Nitric oxide donors in the treatment of cardiovascular and pulmonary diseases.一氧化氮供体在心血管和肺部疾病治疗中的应用
Am Heart J. 1995 Mar;129(3):604-13. doi: 10.1016/0002-8703(95)90291-0.
2
Nitric oxide: from discovery to the clinic.
Trends Pharmacol Sci. 1998 Nov;19(11):436-8. doi: 10.1016/s0165-6147(98)01265-6.
3
[Role of NO in cardiovascular and respiratory physiology].
Arch Int Physiol Biochim Biophys. 1994 Jul-Aug;102(4):A3-9. doi: 10.3109/13813459109045390.
4
[Which future in cardiovascular therapy for nitric oxide and its derivatives?].一氧化氮及其衍生物在心血管治疗中的未来走向如何?
Ann Pharm Fr. 2013 Mar;71(2):84-94. doi: 10.1016/j.pharma.2012.12.004. Epub 2013 Jan 23.
5
[Role of nitric oxide in respiratory physiology and in the physiopathology of pulmonary diseases].[一氧化氮在呼吸生理学及肺部疾病病理生理学中的作用]
Rev Mal Respir. 1996;13(4):381-8.
6
Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential.吸入一氧化氮:一种选择性肺血管扩张剂:当前用途及治疗潜力。
Circulation. 2004 Jun 29;109(25):3106-11. doi: 10.1161/01.CIR.0000134595.80170.62.
7
Nitric oxide and the cardiovascular system.一氧化氮与心血管系统。
J Card Surg. 1994 May;9(3):361-71. doi: 10.1111/j.1540-8191.1994.tb00857.x.
8
Bench to bedside: nitric oxide in emergency medicine.
Acad Emerg Med. 2000 Mar;7(3):285-93. doi: 10.1111/j.1553-2712.2000.tb01081.x.
9
The antiplatelet effects of nitrates: is it of clinical significance in patients with cardiovascular disease?硝酸盐的抗血小板作用:在心血管疾病患者中是否具有临床意义?
Cardiol Rev. 2010 Jul-Aug;18(4):198-203. doi: 10.1097/CRD.0b013e3181d74582.
10
Nitric oxide: an environmental pollutant as a therapeutic agent.
J Okla State Med Assoc. 1995 Jan;88(1):17-23.

引用本文的文献

1
Nitric Oxide-cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension.一氧化氮-cGMP 通路在低氧性肺动脉高压实验模型中的调节作用。
J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):665-676. doi: 10.1177/10742484211014162. Epub 2021 May 8.
2
Nitric oxide modulators: an emerging class of medicinal agents.一氧化氮调节剂:一类新兴的药物制剂。
Indian J Pharm Sci. 2012 Nov;74(6):487-97. doi: 10.4103/0250-474X.110572.